Background: Esophagectomy is frequently accompanied by substantial complications with secondary disturbance of the immune system. After esophagectomy for adenocarcinoma of the distal esophagus and/or gastroesophageal junction, the majority of patients develops an early recurrence and dies within 2 years. The aim of this study was to determine the relevance of perioperative complications on the timing of death due to recurrence. Methods: A consecutive series of 351 patients who underwent esophagectomy for adenocarcinoma of the esophagus and gastroesophageal junction was reviewed. Results: Of the 351 included patients, 191 patients (54%) died due to recurrence of esophageal adenocarcinoma. Of these 191 patients, 77 (40%), 138 (72%), and 186 patients (97%) died before 12, 24, and 60 months, respectively. Multivariate Cox regression analysis demonstrated that T-stage, lymph node ratio Ͼ0.20, the presence of extracapsular lymph node involvement, but not complications were significant factors for the prediction of death due to cancer recurrence. However, in the patients who died, multivariate Cox regression analysis demonstrated that not only the presence of extracapsular lymph node involvement but also the occurrence of complications were significantly related with a shorter time interval until death due to recurrence.
However, these advances have failed to translate into a substantial improvement of long-term survival after surgical resection with 5-year survival rates rarely exceeding 30%. 6,8 -11 Despite comprehensive preoperative staging to select patients for potentially curative surgery, many have unrecognized metastatic disease at the time of first presentation and later present with locoregional, hematogenous, and/or transcelomic recurrences. Disappointingly, even in patients who were operated on with curative intent, the majority develops recurrence and dies within 2 years. 7, [12] [13] [14] [15] [16] Only a minority of patients developing recurrence suffers from relatively late recurrence. This marked difference in biologic behavior probably depends both on tumor characteristics and on host factors. It has been suggested that potent immunosurveillance is of pivotal importance to eradicate microscopic residual disease after surgical resection. [17] [18] [19] Major surgical resection is frequently accompanied by substantial complications with secondary disturbance of the immune system. [17] [18] [19] It could be hypothesized that these complications might have a negative impact on immunosurveillance and thus on tumor recurrence and long-term survival.
To our knowledge, no attention has been paid to the predictors of timing of death due to recurrence after esophagectomy. It remains unknown whether patients who die due to an early recurrence had more advanced disease at the time of operation or had a secondary disturbance of the immune system due to the presence of perioperative complications. Therefore, the aim of the present study was to determine the factors associated with survival due to cancer recurrence after intentionally curative esophagectomy for adenocarcinoma of the distal esophagus and gastroesophageal junction (GEJ) and especially to determine the relevance of complications to the time interval until death due to cancer recurrence.
PATIENTS AND METHODS
Between January 1993 and January 2003, a consecutive series of 351 patients underwent esophagectomy for adenocarcinoma of the esophagus and/or GEJ. Patients did not receive pre-or postoperative chemo-and/or radiation therapy. Clinicopathologic data, including complications, from all operated patients were permanently collected in a prospective database.
Preoperative staging was done with endoscopy with histologic biopsy, endosonography, external sonography of the neck, computed tomography scan and, on indication, positron emission tomography. Surgery was performed/supervised by 1 of 3 experienced surgeons (ORCB, HO, JJBvL) at the Academic Medical Center at the University of Amsterdam, a tertiary referral center with a wide experience in esophageal surgery. Operations were performed with curative intent, ie, in the absence of local irresectability and/or distant metastases (including tumor positive cervical lymph nodes or irresectable celiac nodes). Operations were performed via the transhiatal or transthoracic approach. During transhiatal esophagectomy, the mid-to distal esophagus was dissected under direct vision through the widened hiatus of the diaphragm. The tumor and its adjacent lymph nodes were dissected en-bloc. During transthoracic esophagectomy, a right-sided postero-lateral thoracotomy was performed. The esophagus was resected en-bloc with all (peri-) esophageal tissue in the mediastinum including the thoracic duct, azygos vein, ipsilateral pleura, and lymph nodes.
The subcarinal nodes and the origin of left gastric artery were marked in the resection specimen. Pathologic findings were described on a standardized form. The pTNM-stage, differentiation grade, radicality of resection, total number of resected lymph nodes and total number of positive lymph nodes, including their location were recorded. The lymph node ratio was defined as the ratio between the total amount of positive lymph nodes divided by the total amount of resected nodes. Lymph nodes were cut in 2 and routine hematoxylin and eosin staining was performed using a standardized protocol. Extracapsular lymph node involvement (LNI) was defined as metastatic adenocarcinoma extending through the nodal capsule into the perinodal fatty tissue.
Definition of Complications
Complications were categorized as medical (including infectious complications) or complications directly attributable to surgical technique. Medical complications included cardiac complications (atrial fibrillation, myocardial ischemia, heart failure, cerebral infarction), respiratory failure (diagnosed with blood gas criteria with or without mechanical ventilatory support), atelectasis, pulmonary embolism, and renal failure. Infectious complications included wound infection, pleural empyema, pneumonia (defined as a new infiltrate on chest x-ray, accompanied by purulent sputum or fever, for which treatment with antibiotics was started), and sepsis.
Technical complications were recorded as chylothorax, chyloperitoneum, anastomotic leakage (including both radiologic and clinical leakages), ischemia of the gastric tube, hemorrhage, recurrent laryngeal nerve palsy, diaphragmatic herniation, and dehiscence of the fascia.
Follow-up
All patients were seen at the outpatient clinic at 3 to 4 months intervals during the first 2 years and every 6 months thereafter for 3 years. After 5 years, follow-up was obtained by telephone from the patient or the patient's family practitioner. Follow-up extended to August 2005 ensuring a minimal potential follow-up of 32 months. Follow-up was complete in all patients. Recurrence of disease was only diagnosed on clinical grounds. Radiologic modalities were not routinely used. When recurrence was suspected, additional investigations were performed on indication.
Definition of Recurrence Pattern
Recurrences were classified as hematogenous recurrence, locoregional recurrence, and transcelomic (pleural/ peritoneal) recurrence. Recurrence at cervical-, celiac-, or paraaortic lymph nodes was classified as locoregional recurrence. Simultaneous locoregional and hematogenous disease was classified as hematogenous recurrence.
Statistics
Statistical calculations were performed using SPSS version 12.0 (Statistical Package for the Social Sciences, Chicago, IL). The primary end point of the analysis was disease specific survival (defined as time from date of surgery to date of death as a result of disease recurrence). To perform statistical analysis in a homogeneous group, patients who died due to postoperative complications and patients who died due to unrelated causes were excluded. Cox regression models were used to examine the association between potential predictors and the time until death as a result of esophageal cancer. The following potential predictors were analyzed; age, sex, operative approach, American Society of Anesthesiologists classification, pT-stage, pN-stage, presence of positive truncal nodes, lymph node ratio (categorized into Յ0.20 or Ͼ20% 20 ), the presence of extracapsular LNI, presence of Barrett mucosa, differentiation grade, microscopically irradical resection, and the presence of medical or surgical complications. The Cox proportional-hazards regression model was used for both univariate and multivariate analyses. The models in the present analysis were constructed (1) to identify factors associated with death due to recurrence and (2) to identify prognostic factors in patients who died due to recurrence.
Variables achieving a probability value of less than 0.1 in the univariate analysis were subsequently introduced in a multivariate stepwise proportional-hazard analysis (Cox model) to identify those variables significantly associated with death due to recurrence and timing of death due to recurrent disease. Results are given as hazard ratios with their 95% confidence interval. P-values Ͻ0.05 (2-sided) were considered statistically significant.
RESULTS
Between January 1993 and January 2003 a consecutive series of 351 patients underwent esophagectomy for malignant disease of the esophagus and/or GEJ. The following patients were excluded from this study; 8 patients in whom tumor was left behind macroscopically and 10 patients who died of postoperative complications (3%). Furthermore, 22 patients who died during follow-up due to unrelated disease were excluded from this analysis; 8 patients due to myocardial infarction, 6 patients due to cerebral infarction, 5 patients due to pulmonary disease, 1 patient due to pathologically proven primary pancreatic cancer, 1 patient due to pathologically proven primary lung cancer, and 1 patient with Parkinson disease. Five (1%) patients who experienced recurrence at last follow-up, but were still alive, were censored in survival analyses.
Risk Factors for Death Due to Cancer Recurrence
The clinicopathologic characteristics of 191 patients (62%) who died of recurrence and 120 patients (38%) who were alive are given in Table 1 . In univariate analysis, the radicality of resection, the depth of invasion (T-stage), the presence of lymphatic dissemination, the presence of positive celiac nodes, a lymph node ratio Ͼ0.20, the presence of extracapsular LNI and the differentiation grade of the tumor and the presence of medical or surgical complications were all significantly associated with death from recurrence of adenocarcinoma of the distal esophagus and/or GEJ ( Table  2 ). There were no significant differences in survival time between the 3 operating or supervising surgeons (P ϭ 0.258).
Multivariate Cox regression analysis demonstrated that T-stage, a lymph node ratio Ͼ0.20 and the presence of extracapsular LNI were significant factors for the development of cancer recurrence ( Table 3 ). The presence of medical or surgical complications was not related with cancer recurrence in multivariate analysis. 
Time Interval Until Death Due to Cancer Recurrence
Of the 191 patients who died due to recurrence of esophageal adenocarcinoma, 77 patients (40%), 138 patients (72%), and 186 patients (97%) died before 12, 24, and 60 months, respectively. Almost 3 quarters died within 2 years and only 5 patients (3%) died due to recurrence after 5 years. To identify which factors are responsible for the time interval until death due to recurrence, univariate Cox regression analysis was performed. This analysis revealed that besides conventional pathologic factors, (such as depth of invasion, the presence of lymphatic dissemination, the lymph node ratio, the presence of extracapsular LNI), also the occurrence of medical and/or surgical complications was associated with a shorter time interval until death due to cancer recurrence (Table 4) . Multivariate Cox regression analysis demonstrated that the presence of extracapsular LNI and the occurrence of medical and/or surgical complications were significantly related with a shorter time interval until death due to cancer recurrence ( Table 5) .
The presence of medical or surgical complications (P ϭ 0.030), especially more wound infections (P ϭ 0.033) and more sepsis (P ϭ 0.013) was related to a shorter time to death due to recurrence. Also the presence of surgical complications, especially chylothorax (P Ͻ 0.001) was related with a shorter time to death due to recurrence ( Table 6 ). The operating surgeon was not related with timing of death due to recurrence (P ϭ 0.439).
DISCUSSION
Despite extensive preoperative staging, 60% of the patients treated in our hospital developed cancer recurrence within 60 months after (intentionally) curative surgery. Almost 3 quarters of cancer related deaths occurred within 2 years after surgery, which is in line with other studies. 7, [12] [13] [14] [15] [16] Only a small proportion developed a recurrence after 5 years.
In various malignancies, a relation has been described between postoperative complications and recurrence of can- cer. 16, 21, 22 In esophageal cancer, a prognostic relation between the presence of complications after esophagectomy and overall survival has been reported before. 6, 23 However, in those earlier studies, no effect of complications was identified on tumor specific survival and thus the impact of complications on cancer recurrence remained unclear. A study focusing only on anastomotic leakage did not find a long-term survival effect due to this complication, but the number of patients with anastomotic leakage (n ϭ 14) was too small to draw definite conclusions. 24 In the present study, classic pathologic factors, which indicate advanced disease, such as advanced T-stage, lymph node ratio Ͼ0.20, and the presence of extracapsular LNI, were all independent prognostic factors associated with death due to cancer recurrence. 11, [25] [26] [27] [28] [29] Although the presence of complications was related with survival in univariate analysis in multivariate analysis, the occurrence of complications was not an independent predictor of death due to recurrence. This might indicate that the primary tumor biology determines who will die of recurrence and not a hypothetical negative impact of postoperative complications on oncological immunosurveillance. Possibly, the (indirect) relation between postoperative complications and death due to recurrence can be explained by the fact that the operative procedure is technically more demanding in patients with more advanced disease and therefore is accompanied with more postoperative complications. Another explanation might be that patients with more advanced disease have a higher load of unrecognized (micro) metastatic tumor that is left behind and makes the patient more susceptible for complications.
Interestingly, the presence of postoperative complications did not have a significant effect on recurrence per se, but was related to the timing of death due to recurrence in multivariate analysis. The occurrence of postoperative complications was an independent predisposing factor for a short time interval until death due to cancer recurrence. It is unlikely that this effect can be explained by a difference in preoperative comorbidity because American Society of Anesthesiologists classification was not a significant factor in univariate analysis. It could be hypothesized that complications are accompanied by a secondary disturbance of the immune system. After major surgery there is a profound but self-limiting systemic inflammatory response in patients with an uncomplicated postoperative course. However, patients who develop postoperative complications suffer a "double hit," the first as a result of surgery and the second from their complications. Possibly, these circumstances enhance that residual microscopic disease can develop more rapidly to become clinically manifest and fatal. [17] [18] [19] 22 This is further underlined by the fact that especially patients who developed sepsis and patients who had chyle leakage died earlier. The first group of patients probably suffers from a major double hit and the second group of patients suffers from an ongoing loss of fluids and proteins (consisting of eg, lymphocytes and immunoglobulines), 30, 31 which further deteriorates the already malnourished and immunocompromised patient with adenocarcionoma of the esophagus and GEJ. 30 -33 In conclusion, the results of the present study indicate that the relation between postoperative complications and cancer recurrence per se is not causal. However, postoperative complications are significantly associated with a short time interval until death due to cancer recurrence in multivariate analysis. A possible explanation for this phenomenon is that immunologic host factors enhance microscopic residual disease to develop more rapidly into fatal recurrence. 
